HeartWare Inc.

FDA inspection history across 2 sites, 2011 to 2018

2
Form 483s
2
Warning letters
2
EIRs

Every document, by year

  • Form 483
  • Warning letter
  • EIR

2011: one inspection report; 2013: one inspection report; 2014: two warning letters; 2016: one Form 483; 2018: one amended 483.

The story so far

Built from the dates and citations on the documents themselves.

  1. 2011–18Two inspection reports, two warning letters, one Form 483 and one amended 483, at Miami Lakes, Florida and Framingham, Massachusetts.
  2. 2018The longest 483 on file: 7 observations over 16 pages at Miami Lakes, Florida.

Cited most

Across all HeartWare observations on file

The complete HeartWare file.

All 6 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.

$1,272$1,496

15% off buying them one by one

Sites

Documents

6 on file, newest first
DateDocumentPrice
2018-07-12Amended 483 Amended 483$99
2016-05-04483 Form 483$99
2014-06-02Warning letter Warning letter$99
2014-06-02Warning letter Warning letter$99
2013-03-29EIR EIR$550
2011-07-20EIR EIR$550

FEI number 3007042319 · most recent document Jul 12, 2018

About HeartWare Inc.

How many FDA Form 483s has HeartWare Inc. received?

FDA Intel has 2 Form 483s on file for HeartWare Inc.; the most recent is dated Jul 12, 2018.

When was HeartWare Inc. last inspected by FDA?

The most recent FDA inspection document on file for HeartWare Inc. is a Form 483 dated Jul 12, 2018, for the site in Miami Lakes, Florida.

What did FDA cite at HeartWare Inc.?

The regulations cited most in the observations on file for HeartWare Inc. are 21 CFR 820.30(a) (Design controls), 3 times; 21 CFR 803.17 (What are the requirements for developing, maintaining, and implementing written MDR procedures that apply to me?), 2 times; 21 CFR 820.100(a) (Corrective and preventive action), 2 times.

Has HeartWare Inc. received an FDA warning letter?

Yes. FDA Intel has 2 FDA warning letters on file for HeartWare Inc.; the most recent is dated Jun 2, 2014.